| Not Yet Recruiting | CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma NCT07383233 | Qi deng | Phase 1 |
| Recruiting | MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan a NCT07493538 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Not Yet Recruiting | Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis NCT07499765 | Centre Henri Becquerel | N/A |
| Recruiting | BY002 IIT Study in R/R Acute Leukemia NCT07270770 | The First Affiliated Hospital of Soochow University | Phase 1 |
| Recruiting | A Study of Revumenib and Mezigdomide in People With Leukemia NCT07356154 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML NCT07157514 | Actinium Pharmaceuticals | Phase 2 / Phase 3 |
| Recruiting | Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSC NCT07362095 | Zhujiang Hospital | Phase 1 / Phase 2 |
| Recruiting | Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults NCT07048730 | University Hospital, Bordeaux | N/A |
| Not Yet Recruiting | Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy NCT07087847 | Ruijin Hospital | N/A |
| Not Yet Recruiting | Bleeding and Thrombotic Risk Prediction in Acute Leukemia: Clinical Utility of the Siriraj Acute Myeloid/Lymph NCT07108686 | Assiut University | — |
| Recruiting | Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia NCT07101497 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Recruiting | Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT NCT06984536 | Peking University People's Hospital | Phase 2 |
| Recruiting | Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant NCT06315309 | University of Alabama at Birmingham | Phase 2 |
| Recruiting | Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding NCT06947044 | Donald Arnold | N/A |
| Recruiting | Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia Patients NCT06937554 | University of Rome Tor Vergata | — |
| Recruiting | Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant NCT06265584 | University of Alabama at Birmingham | Phase 2 |
| Not Yet Recruiting | The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults NCT06876701 | Ruijin Hospital | EARLY_Phase 1 |
| Recruiting | Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing NCT06907797 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Feasibility of a Multi-omics Platform for Hematological Malignancies NCT07445438 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Recruiting | Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) NCT06803745 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Active Not Recruiting | Pilot of a Trial Enrollment Diversity Dashboard NCT06795139 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant NCT06575296 | City of Hope Medical Center | Phase 1 |
| Recruiting | Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device i NCT06697275 | University Hospital, Clermont-Ferrand | N/A |
| Recruiting | Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. NCT06356922 | Nantes University Hospital | Phase 1 / Phase 2 |
| Suspended | Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia NCT06421155 | Case Comprehensive Cancer Center | N/A |
| Recruiting | A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphobla NCT06207123 | University of Chicago | Phase 1 / Phase 2 |
| Recruiting | A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Tr NCT05589896 | Ossium Health, Inc. | Phase 1 / Phase 2 |
| Recruiting | Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia NCT06058572 | Tata Memorial Centre | Phase 2 |
| Recruiting | The Effect of Serum Ferritin in irAE NCT06702566 | Tianjin Medical University Cancer Institute and Hospital | N/A |
| Recruiting | Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Ly NCT06058858 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are In NCT06279494 | Peking University People's Hospital | Phase 1 / Phase 2 |
| Recruiting | Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06001788 | Kura Oncology, Inc. | Phase 1 |
| Recruiting | Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemi NCT06585345 | The General Hospital of Western Theater Command | Phase 1 / Phase 2 |
| Recruiting | Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction NCT06211166 | Peking University People's Hospital | — |
| Active Not Recruiting | HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantati NCT06001385 | Center for International Blood and Marrow Transplant Research | Phase 2 |
| Recruiting | Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leuka NCT06814444 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Unknown | Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors NCT06026839 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Active Not Recruiting | Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients NCT07122479 | Northwell Health | N/A |
| Completed | Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia NCT07036809 | Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy | — |
| Recruiting | Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome NCT05902416 | Peking University People's Hospital | — |
| Recruiting | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE NCT07403630 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Recruiting | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Unknown | Study of miRNA-155 in Acute Leukemia NCT05809050 | Sohag University | — |
| Recruiting | Use of GnRHa During Chemotherapy for Fertility Protection NCT05328258 | Kenny Rodriguez-Wallberg | Phase 3 |
| Active Not Recruiting | A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer NCT05428176 | City of Hope Medical Center | N/A |
| Unknown | Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies NCT05654766 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | — |
| Unknown | M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia NCT05739630 | The First Affiliated Hospital of Soochow University | Phase 2 / Phase 3 |
| Unknown | Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation NCT05634915 | The First Affiliated Hospital of Soochow University | Phase 4 |
| Unknown | Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) NCT05587088 | Hospital Universitario San Ignacio | Phase 1 / Phase 2 |
| Unknown | The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance NCT05601895 | Nanfang Hospital, Southern Medical University | — |
| Withdrawn | Cryopreserved MMUD BM With PTCy for Hematologic Malignancies NCT05170828 | Ossium Health, Inc. | Phase 1 |
| Recruiting | Olverembatinib for FGFR1-rearranged Neoplasms NCT05521204 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Completed | Study of Radiolabeled Revumenib in Adults With Acute Leukemia NCT05406817 | Syndax Pharmaceuticals | Phase 1 |
| Active Not Recruiting | Study of 3D189 in Patients With Hematologic Malignancies NCT05320809 | 3D Medicines | Phase 1 |
| Active Not Recruiting | Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic NCT05316701 | Orca Biosystems, Inc. | Phase 3 |
| Unknown | Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute L NCT05335226 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Completed | Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Req NCT05298930 | Centre Leon Berard | N/A |
| Completed | PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation NCT05120570 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Recruiting | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia NCT04224974 | Canadian Cancer Trials Group | N/A |
| Unknown | Physical Fitness Impact of Early Physiotherapy Intervention With a Standardized Exercise Therapy Program in Ad NCT04899882 | University Hospital, Angers | N/A |
| Terminated | Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease NCT04328714 | Edwin Horwitz | Phase 1 |
| Completed | Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer NCT05035615 | Becton, Dickinson and Company | — |
| Active Not Recruiting | HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide NCT04904588 | Center for International Blood and Marrow Transplant Research | Phase 2 |
| Completed | Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings NCT04969601 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Terminated | Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL NCT05071482 | Institute of Hematology & Blood Diseases Hospital, China | Phase 4 |
| Recruiting | Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft NCT05088356 | Stanford University | Phase 1 |
| Completed | Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study NCT05053100 | Mayo Clinic | — |
| Recruiting | Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Recruiting | AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depl NCT04099966 | Mitchell Cairo | Phase 2 |
| Unknown | Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia NCT04767165 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | N/A |
| Unknown | Evaluation of Brain Changes in ALL Patients on Therapy NCT04767152 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | N/A |
| Recruiting | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hemat NCT04195633 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia NCT04552912 | Duke University | N/A |
| Unknown | Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leu NCT04674345 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Completed | Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplas NCT04339101 | City of Hope Medical Center | Phase 2 |
| Not Yet Recruiting | Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo- NCT04451200 | Institut Paoli-Calmettes | Phase 2 |
| Withdrawn | Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer NCT03739606 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | ATG Plus PTCy vs ATG for CGVHD Prophylaxis NCT04202835 | McMaster University | Phase 2 |
| Completed | Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospita NCT04597086 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood Cells NCT04551235 | National Taiwan University Hospital | — |
| Active Not Recruiting | TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT NCT04281199 | City of Hope Medical Center | Phase 1 |
| Completed | CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML NCT04151706 | Robert Lowsky | Phase 2 |
| Recruiting | BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) NCT04187105 | University of Illinois at Chicago | Phase 2 |
| Unknown | The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human NCT04298502 | Peking University People's Hospital | — |
| Completed | Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study. NCT04182074 | University of Hull | — |
| Active Not Recruiting | Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancie NCT04013685 | Orca Biosystems, Inc. | Phase 1 |
| Recruiting | Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukem NCT03970096 | Fred Hutchinson Cancer Center | Phase 2 |
| Recruiting | CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia NCT04157569 | Navy General Hospital, Beijing | — |
| Unknown | Immunophenotyping of Acute b Cell Lymphoblstic Leukemia NCT04084327 | South Egypt Cancer Institute | — |
| Recruiting | Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Bloo NCT03779854 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution NCT03959241 | Medical College of Wisconsin | Phase 3 |
| Terminated | Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia NCT03672851 | Second Affiliated Hospital of Xi'an Jiaotong University | Phase 1 |
| Completed | Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia ( NCT03792256 | Children's Oncology Group | Phase 1 |
| Completed | Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of th NCT03959007 | University Hospital, Lille | N/A |
| Completed | Evaluation of Bibliotherapy by Students and Patients With Cancer NCT03969082 | University Hospital, Ghent | N/A |
| Recruiting | CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT NCT03810196 | Children's Hospital of Philadelphia | N/A |
| Completed | Association Between Telomere Length and Cardiac Dysfunction NCT04409379 | Air Force Military Medical University, China | — |
| Unknown | Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute NCT03743909 | Assiut University | — |
| Unknown | Action of the Vidaza on the Atrial Fibrillation NCT03298321 | Hospices Civils de Lyon | — |
| Withdrawn | A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoieti NCT04331483 | Centre Leon Berard | N/A |
| Unknown | Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia NCT03756675 | Peking University People's Hospital | — |
| Completed | Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematolo NCT03698656 | University Hospital, Toulouse | — |
| Terminated | Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant NCT03588936 | Medical College of Wisconsin | Phase 1 |
| Completed | CD19-CART Treatment for ALL NCT03232619 | Bioray Laboratories | Phase 1 / Phase 2 |
| Unknown | iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patient NCT03364257 | Pathoquest | — |
| Recruiting | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders NCT03314974 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment NCT03493906 | Rigshospitalet, Denmark | N/A |
| Active Not Recruiting | High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children Wit NCT03178617 | City of Hope Medical Center | N/A |
| Completed | Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation NCT03434730 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT NCT03412409 | Peking University People's Hospital | Phase 2 |
| Completed | Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia NCT03669172 | Martín, José Luis Díez, M.D. | Phase 1 / Phase 2 |
| Unknown | Dependence Receptors and Leukemia NCT03278145 | Hospices Civils de Lyon | — |
| Unknown | Expression of TET1 Gene in Acute Leukaemia NCT03267485 | Assiut University | — |
| Completed | Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients W NCT03096782 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy NCT03279900 | Indonesia University | — |
| Completed | Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related NCT03595800 | Institut Paoli-Calmettes | Phase 3 |
| Completed | Electronic Database for the Follow up of the ATG_FamilyStudy NCT03042676 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Withdrawn | iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML NCT03138395 | University of Florida | — |
| Completed | Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction NCT03316456 | Masonic Cancer Center, University of Minnesota | — |
| Active Not Recruiting | Cancer Stem Cells in Acute Leukemia NCT03735797 | Sanford Health | — |
| Terminated | A Study of ONO-7475 in Patients With Acute Leukemias NCT03176277 | Ono Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Completed | High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in P NCT03128359 | City of Hope Medical Center | Phase 2 |
| Completed | UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep NCT02722668 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Recruiting | Familial Investigations of Childhood Cancer Predisposition NCT03050268 | St. Jude Children's Research Hospital | — |
| Unknown | Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotrans NCT03297528 | Peking University People's Hospital | Phase 2 |
| Completed | Feasiblity and Safety of Home-based Intensive Chemotherapy NCT04904211 | Rigshospitalet, Denmark | N/A |
| Completed | Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and M NCT02730299 | Gamida Cell ltd | Phase 3 |
| Completed | A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia NCT02930109 | Prescient Therapeutics, Ltd. | Phase 1 / Phase 2 |
| Terminated | Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Pa NCT02877082 | Emory University | Phase 2 |
| Completed | Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic NCT02693899 | Nantes University Hospital | — |
| Unknown | CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT. NCT02752243 | Peter Bader | Phase 1 / Phase 2 |
| Recruiting | Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and R NCT02677064 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia NCT02822326 | Guangdong Provincial People's Hospital | Phase 1 |
| Completed | Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients NCT02580071 | China Medical University Hospital | N/A |
| Completed | Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplant NCT02356159 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia NCT02440178 | Seoul National University Hospital | Phase 2 |
| Completed | Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 130 NCT02345850 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy NCT02487069 | Nanfang Hospital, Southern Medical University | N/A |
| Recruiting | Umbilical Cord Blood Transplantation From Unrelated Donors NCT03016806 | University of Rochester | — |
| Completed | Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia NCT02353559 | University Health Network, Toronto | N/A |
| Recruiting | A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leuke NCT06076226 | Zhejiang University | — |
| Completed | Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acut NCT02445378 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) NCT02208037 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Nonmyeloablative Haploidentical Transplant Followed by MLN9708 NCT02169791 | Northside Hospital, Inc. | Phase 2 |
| Unknown | Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferat NCT02320656 | Institut Paoli-Calmettes | N/A |
| Unknown | Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia NCT03408210 | Affiliated Hospital to Academy of Military Medical Sciences | N/A |
| Unknown | Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia NCT03408223 | Affiliated Hospital to Academy of Military Medical Sciences | N/A |
| Completed | Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome a NCT02038361 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Exercise and Quality of Life in Leukemia Patients NCT02246907 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Unknown | Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT NCT01956630 | Affiliated Hospital to Academy of Military Medical Sciences | Phase 1 / Phase 2 |
| Completed | Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractor NCT01900509 | St. Jude Children's Research Hospital | Phase 1 |
| Completed | A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia NCT01814488 | Gruppo Italiano Trapianto di Midollo Osseo | Phase 2 |
| Completed | PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism NCT01855698 | Gruppo Italiano Malattie EMatologiche dell'Adulto | — |
| Terminated | Phase I Study of Lenalidomide in Patients With Acute Leukemia NCT01615042 | Mehrdad Abedi, MD | Phase 1 |
| Unknown | Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patient NCT01695512 | Heidelberg University | — |
| Completed | Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy NCT01661413 | The Hospital for Sick Children | — |
| Terminated | Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor NCT01598025 | Memorial Sloan Kettering Cancer Center | N/A |
| Terminated | Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells NCT01624701 | Singapore General Hospital | Phase 1 / Phase 2 |
| Completed | Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell NCT01660607 | Stanford University | Phase 1 / Phase 2 |
| Suspended | ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS NCT01709396 | Ottawa Hospital Research Institute | Phase 2 |
| Unknown | HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, M NCT01509300 | Asan Medical Center | Phase 1 / Phase 2 |
| Completed | Respiratory Syncytial Virus - RSV Protocol NCT01502072 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients NCT01603290 | National Taiwan University Hospital | — |
| Unknown | Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemi NCT01498016 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Unknown | Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation NCT01472055 | Seoul National University Hospital | Phase 2 |
| Completed | Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) NCT01404520 | Universitetshospitalernes Center for Sygepleje | N/A |
| Unknown | Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnos NCT02344966 | Yonsei University | — |
| Completed | Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome NCT01314599 | PharmaMar | Phase 1 |
| Completed | Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases NCT01336712 | Northside Hospital, Inc. | Phase 2 |
| Terminated | Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps NCT01350258 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 / Phase 2 |
| Completed | Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML NCT01496547 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Completed | Fungemia in Hematologic Malignancies NCT02451592 | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | — |
| Unknown | Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Eva NCT02344953 | Yonsei University | — |
| Unknown | Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and A NCT01239485 | Seoul National University Hospital | Phase 1 |
| Completed | Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study NCT01557686 | Universitetshospitalernes Center for Sygepleje | EARLY_Phase 1 |
| Unknown | Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT01800643 | Hospital Israelita Albert Einstein | Phase 2 / Phase 3 |
| Completed | A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for NCT01036009 | University of California, San Francisco | Phase 2 |
| Completed | Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies NCT00988013 | University of Illinois at Chicago | N/A |
| Completed | Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off- NCT01362985 | Genzyme, a Sanofi Company | — |
| Enrolling By Invitation | Pathogenesis of Hematologic Malignancies NCT01728402 | OHSU Knight Cancer Institute | — |
| Completed | Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unre NCT00823316 | Medipost Co Ltd. | Phase 1 / Phase 2 |
| Completed | Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children NCT01385891 | Istituto Giannina Gaslini | Phase 2 / Phase 3 |
| Terminated | A Study for Patients With Acute Leukemia NCT01214655 | Eli Lilly and Company | Phase 1 |
| Completed | Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune S NCT00520130 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in NCT00852709 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors NCT00701844 | University of North Carolina, Chapel Hill | N/A |
| Completed | An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clin NCT01321372 | University Health Network, Toronto | — |
| Completed | Trial of AVN-944 in Patients With Advanced Hematologic Malignancies NCT00273936 | Vertex Pharmaceuticals Incorporated | Phase 1 |
| Completed | A Phase I Trial of ZIO-101 in Hematologic Cancers NCT00592046 | Alaunos Therapeutics | Phase 1 |
| Completed | Physical Activity in Acute Lymphoblastic Leukemia (ALL) NCT06783738 | University of California, Irvine | N/A |
| Completed | Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies NCT01499147 | University of Illinois at Chicago | N/A |
| Completed | Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 NCT03469921 | Institut Paoli-Calmettes | — |
| Active Not Recruiting | Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukem NCT00899223 | Alliance for Clinical Trials in Oncology | — |
| Completed | Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation NCT01020175 | European Society for Blood and Marrow Transplantation | Phase 3 |
| Active Not Recruiting | Cytogenetic Studies in Acute Leukemia and Multiple Myeloma NCT00048958 | Alliance for Clinical Trials in Oncology | — |
| Available | Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients NCT05974410 | AVM Biotechnology Inc | — |
| Completed | Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acu NCT02823132 | Centre Hospitalier Universitaire Dijon | — |